Key Data:
Estimated Investment
$400m
Completion
Completed in late 2008, pre-approval validation completed in 2009
Key Players:
Sponsors
Amylin Pharmaceuticals, Amylin Ohio LLC, Alkermes, Eli Lilly
Lead Contractors and Designers
J& B Steel
Financial
Amylin Pharmaceuticals